We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

136 hedge funds and large institutions have $2.79B invested in SpringWorks Therapeutics in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 52 increasing their positions, 46 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

13% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 46

12% more call options, than puts

Call options by funds: $33.6M | Put options by funds: $29.9M

7.93% more ownership

Funds ownership: 92.29% → 100.23% (+7.9%)

1% less capital invested

Capital invested by funds: $2.82B → $2.79B (-$24.9M)

6% less funds holding

Funds holding: 144 → 136 (-8)

36% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 22

Holders
136
Holders Change
-8
Holders Change %
-5.56%
% of All Funds
2.15%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.11%
New
14
Increased
52
Reduced
46
Closed
22
Calls
$33.6M
Puts
$29.9M
Net Calls
+$3.66M
Net Calls Change
+$6.36M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$120M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$74.3M
3
Norges Bank
Norges Bank
Norway
+$21.4M
4
EC
EcoR1 Capital
California
+$18.6M
5
Marshall Wace
Marshall Wace
United Kingdom
+$17M

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$18.4M
2
Ameriprise
Ameriprise
Minnesota
-$12.1M
3
DM
Deerfield Management
New York
-$11.6M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$9.9M
5
Two Sigma Investments
Two Sigma Investments
New York
-$4.85M
Name Holding Trade Value Shares
Change 		Change in
Stake
AssetMark Inc
126
AssetMark Inc
California
$24K +$24.7K +432 New
QT
127
Quantbot Technologies
New York
$17K -$73.9K -1,292 -81%
S
128
SignatureFD
Georgia
$10K +$9.27K +162 +1,013%
Daiwa Securities Group
129
Daiwa Securities Group
Japan
$8K – – –
CAPTRUST Financial Advisors
130
CAPTRUST Financial Advisors
North Carolina
$5K -$3.78K -66 -42%
TWA
131
TCI Wealth Advisors
Arizona
$4K -$4.41K -77 -55%
MPWT
132
MassMutual Private Wealth & Trust
Connecticut
$1K +$858 +15 New
MFT
133
Moisand Fitzgerald Tamayo
Florida
$1K +$1.32K +23 New
Macquarie Group
134
Macquarie Group
Australia
$22 – – –
Ameriprise
135
Ameriprise
Minnesota
– -$12.1M -195,727 Closed
Two Sigma Investments
136
Two Sigma Investments
New York
– -$4.85M -78,250 Closed
D.E. Shaw & Co
137
D.E. Shaw & Co
New York
– -$3.45M -55,704 Closed
Two Sigma Advisers
138
Two Sigma Advisers
New York
– -$2.11M -34,000 Closed
PP
139
PDT Partners
New York
– -$2.08M -33,500 Closed
Toronto Dominion Bank
140
Toronto Dominion Bank
Ontario, Canada
– -$1.48M -23,882 Closed
TC
141
TwinBeech Capital
New York
– -$1.15M -18,599 Closed
Millennium Management
142
Millennium Management
New York
– -$929K -14,990 Closed
PG
143
Pendal Group
Australia
– -$828K -13,354 Closed
Squarepoint
144
Squarepoint
New York
– -$659K -10,635 Closed
CSS
145
Cubist Systematic Strategies
Connecticut
– -$643K -10,370 Closed
EGM
146
Engineers Gate Manager
New York
– -$574K -9,257 Closed
Qube Research & Technologies (QRT)
147
Qube Research & Technologies (QRT)
United Kingdom
– -$514K -8,297 Closed
Brown Advisory
148
Brown Advisory
Maryland
– -$366K -5,902 Closed
ASN
149
Advisory Services Network
Georgia
– -$363K -5,850 Closed
XT
150
XTX Topco
Cayman Islands
– -$294K -4,736 Closed
3 4 5
6
7

SWTX Hedge Fund Activity: Q1 2022 in Review

136 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q1 2022, worth a combined $2.79B — down 0.88% from $2.82B a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of SWTX and 14 opened new positions — a net loss of 8 holders — while 46 trimmed existing stakes and 52 added.

The largest buyer was Fidelity Investments, adding an estimated $120M. The largest seller was Perceptive Advisors, cutting an estimated $18.4M.

  • 136 institutional investors held SpringWorks Therapeutics (SWTX) as of Q1 2022, down from 144 in Q4 2021.
  • Funds reported $2.79B of SpringWorks Therapeutics stock for Q1 2022, down 0.88% quarter-over-quarter.
  • 14 funds opened new SpringWorks Therapeutics positions in Q1 2022 and 22 closed out, a net change of -8 holders.
  • The largest SpringWorks Therapeutics buyer in Q1 2022 was Fidelity Investments, an estimated $120M added.
  • The largest SpringWorks Therapeutics seller in Q1 2022 was Perceptive Advisors, an estimated $18.4M sold.

Based on aggregated 13F filings for Q1 2022.